《表3 两组不良反应发生情况比较 (n) Table 3 Comparison of adverse events in both groups (n)》
提示：宽带有限、当前游客访问压缩模式
统计数据分析，研究组不良反应发生率为（3.85%），常规组不良反应发生率为（15.38%），差异具有统计学意义（χ2=3.983，P<0.05），见表3。
| 图表编号 | XD0014592500 严禁用于非法目的 |
|---|---|
| 绘制时间 | 2018.01.25 |
| 作者 | 韩春凤 |
| 绘制单位 | 内蒙古乌兰察布市中心医院药剂科 |
| 更多格式 | 高清、无水印（增值服务） |
![表2 组间不良反应发生情况对比[n (%) ]Tab 2 Comparison of adverse reactions between groups[n (%) ]](http://bookimg.mtoou.info/tubiao/gif/YPPJ201902008_04100.gif)
![表3 两组患者不良反应发生率比较[n (%) ]Tab 3 Comparison of the incidence of adverse reactions between patients in two groups[n (%) ]](http://bookimg.mtoou.info/tubiao/gif/TJYK201901016_09800.gif)
相关图表
- 《表2 两组患儿术后不良反应发生情况比较 (n/%) Tab 2 Comparison of postoperative adverse reactions between the two groups (n/%)》2019.01.28
- 《表2 组间不良反应发生情况对比[n (%) ]Tab 2 Comparison of adverse reactions between groups[n (%) ]》2019.01.28
- 《表3 两组不良反应情况对比 (n=33, n/%) Tab 3 Comparison of adverse reactions between the two groups (n=33, n/%)》2019.01.08
- 《表6 3组患者不良反应发生情况比较Tab.6 Comparison of the incidence of adverse reactions in the three groups》2019.01.05
- 《表3 两组患者不良反应发生率比较[n (%) ]Tab 3 Comparison of the incidence of adverse reactions between patients in two groups[n (%) ]》2019.01.20
- 《表3 两组患者不良反应发生率比较n (%) Tab.3Comparison of the incidence of adverse reactions in the two groups n (%)》2019.03.05
- 《表3 不良反应类型及发生率Tab.3 Varieties and prevalence of adverse events》2019.01.19
- 《表4 2组患儿不良反应比较[n (%) ]Table 4 Comparison of adverse reactions in 2 groups of children[n (%) ]》2018.08.15
- 《表2 两组不良反应发生情况比较[n, (%) ]Tab.2 The incidence of adverse reactions in two groups[n, (%) ]》2018.11.01
- 《表3 两组患者术后不良反应发生率比较 (n (%) ) Table 3 Comparison of the incidence of postoperative adverse reactions in the two groups (n》2018.09.25
- 《表3 三组患者不良反应发生率比较Tab 3 Comparison of adverse effects incidence among three groups of cases》2018.08.20
- 《表7 两组患者术中不良事件情况的比较Tab 7 Comparison of the cases with adverse events in the two groups of patients》2018.04.20
- 《表6 两组术后不良反应发生情况比较Tab 6 Comparison of adverse reactions after operation between the two groups》2018.02.20
- 《表3 两组患者不良反应发生率对比 (n) Table 3 Incidence of adverse reactions in the two groups (n)》2018.01.25
- 《表2 两组治疗过程中不良反应比较 (n) Table 2 Comparison of adverse reactions between the two groups during treatment (n)》2018.01.25
- 《表4 不良反应发生率比较 (n) Table 4 Adverse reactions incidence comparison (n)》2018.01.25
- 《表3 研究组与对照组不良反应发生情况对比 (n) Table 3 Comparison of adverse reactions between the study group and the control group (n)》2018.01.25
- 《表2 两组疗效及不良反应比较 (n) Table 2 Comparison of efficacy and adverse reactions between the two groups (n)》2018.01.25
- 《表3 纳入研究PHC患者的不良反应情况 (例) Table 3 Adverse reactions of PHC patients in included studies (cases)》2018.06.30
- 《表3 2组患者安全性不良事件发生情况Tab.3 Outcomes of safety related adverse events of patients in two groups》2018.07.28